Calif. Stem Cell Group’s New Strategy Would ‘Expand’ Research Grants, Increase Outreach

The California Institute for Regenerative Medicine, the Golden State’s stem-cell agency, has unveiled a revised draft strategy that seeks over the next eight years to increase funding opportunities for biotech companies performing stem-cell research, perform more public and legislative outreach, and hire additional grant reviewers.

[Read the full article here]

Comments are closed.